Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina
Listen to José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer from an Argentinian perspective.
Decera Clinical Education Oncology Podcast · Alejandro Nolazco, José Ignacio Nolazco
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer from an Argentinian perspective.
Presenters:
José Ignacio Nolazco, MD
Urology Fellow
Hospital Universitario Austral
Buenos Aires, Argentina
Alejandro Nolazco, MD
Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina
Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.
Link to full program, including associated downloadable slidesets and on-demand Webcast:
https://bit.ly/3kJC5SL
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.